160 related articles for article (PubMed ID: 30824786)
1. Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin.
Ruczyński J; Rusiecka I; Turecka K; Kozłowska A; Alenowicz M; Gągało I; Kawiak A; Rekowski P; Waleron K; Kocić I
Sci Rep; 2019 Mar; 9(1):3247. PubMed ID: 30824786
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
[TBL] [Abstract][Full Text] [Related]
3. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against
Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T
J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial properties of Latarcin 1 derived cell-penetrating peptides.
Budagavi DP; Chugh A
Eur J Pharm Sci; 2018 Mar; 115():43-49. PubMed ID: 29329747
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled oleylamine grafted hyaluronic acid polymersomes for delivery of vancomycin against methicillin resistant Staphylococcus aureus (MRSA).
Walvekar P; Gannimani R; Salih M; Makhathini S; Mocktar C; Govender T
Colloids Surf B Biointerfaces; 2019 Oct; 182():110388. PubMed ID: 31369955
[TBL] [Abstract][Full Text] [Related]
7. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anti-MRSA, and anti-VRE activity of hemin conjugates with amino acids and branched peptides.
Okorochenkov SA; Zheltukhina GA; Mirchink EP; Isakova EB; Feofanov AV; Nebolsin VE
Chem Biol Drug Des; 2013 Oct; 82(4):410-7. PubMed ID: 23663365
[TBL] [Abstract][Full Text] [Related]
9. Transportan 10 improves the anticancer activity of cisplatin.
Izabela R; Jarosław R; Magdalena A; Piotr R; Ivan K
Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):485-97. PubMed ID: 26899863
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
11. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients.
Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L
J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
[TBL] [Abstract][Full Text] [Related]
13. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y
Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Leonard SN; Rybak MJ
J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
[TBL] [Abstract][Full Text] [Related]
15. Different formulations of vancomycin: In vitro antimicrobial activity against clinical isolates of methicillin-resistant Staphylococcus aureus.
Fabri FV; Lolis MA; Gimenes M; Tognim MCB; Caparroz-Assef SM
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):332-337. PubMed ID: 30033164
[TBL] [Abstract][Full Text] [Related]
16. Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide.
Zhang W; Taheri-Ledari R; Hajizadeh Z; Zolfaghari E; Ahghari MR; Maleki A; Hamblin MR; Tian Y
Nanoscale; 2020 Feb; 12(6):3855-3870. PubMed ID: 31996884
[TBL] [Abstract][Full Text] [Related]
17. A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice.
Wang Z; Kong L; Liu Y; Fu Q; Cui Z; Wang J; Ma J; Wang H; Yan Y; Sun J
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625989
[No Abstract] [Full Text] [Related]
18. A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells.
Antonoplis A; Zang X; Huttner MA; Chong KKL; Lee YB; Co JY; Amieva MR; Kline KA; Wender PA; Cegelski L
J Am Chem Soc; 2018 Nov; 140(47):16140-16151. PubMed ID: 30388366
[TBL] [Abstract][Full Text] [Related]
19. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus.
Singh NB; Yim J; Jahanbakhsh S; Sakoulas G; Rybak MJ
Diagn Microbiol Infect Dis; 2018 Aug; 91(4):363-370. PubMed ID: 29807674
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-Functionalized Gold and Silver Nanoparticles as an Antibacterial Nanoplatform Against Methicillin-Resistant Staphylococcus aureus.
Hur YE; Park Y
J Nanosci Nanotechnol; 2016 Jun; 16(6):6393-9. PubMed ID: 27427725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
